One of the best ways to find promising stocks is by identifying firms that have outperformed the industry during periods of weakness.
Astec Industries is coming out of COVID-19 as a stronger company: CEO Barry Ruffalo
Categories
Interviews
Applied UV eyes an untapped global market
Healthcare-associated infection (HAI) is among the worst under-reported health hazards across the globe. According to recent studies, about one in 25 patients
Worthington Industries CFO stays cautious despite recovery in steel demand
The past few months have been quite challenging for manufacturing companies, and the story of Worthington Industries (NYSE: WOR) was no different.
Boomer Naturals: Hitting the bull’s eye during the pandemic
So far this year, we have witnessed how companies have adapted to the new normal of the pandemic lifestyle to drive business.
NovoCure (NVCR): Why this medtech firm matters
Even as COVID-19 is wreaking havoc across the world, cancer continues to kill about 10 million people per year, and the quest
New name better illustrates 360 Finance’s long-term strategy: CFO Alex Xu
360 Finance, Inc. (NASDAQ: QFIN) is all set to assume a new identity this year, continuing its transformation into a uniquely innovative
Resonant is probably the 5G stock you have been looking for
5G is undeniably the next big thing that is set to revolutionize the tech industry. According to a recent study, the 5G
How Mohawk Group is creating a cocktail of tech-enabled consumer brands
When Amazon (NASDAQ: AMZN) combined the capabilities of technology and retail a few years ago, what followed was a revolutionary shift in
Oncology to COVID-19: Karyopharm (KPTI) CEO on what’s ahead
The oncology research space has become rather crowded these days, with numerous clinical-level companies cropping up with novel technologies. While these offer
No concerns on margin side: Trxade (MEDS) CEO Suren Ajjarapu
A lot is being spoken and written about Amazon (NASDAQ: AMZN), Shopify (NYSE: SHOP) and JD.com (NASDAQ: JD) and their prospects in
With IP valued at $34 million, C-Bond Systems offers an unbreakable deal
C-Bond Systems (OTC: CBNT), founded in 2007, is a nanotechnology solutions firm focused at giving glass and other brittle materials better longevity
MamaMancini’s expects Beyond Meat deal to have a better serving post Covid-19
Like all other businesses, the packaged food industry is going through a highly volatile phase, with the coronavirus bringing a paradigm shift
AquaBounty is gearing up for the first US harvest of GM salmon
According to the United Nations (UN), the global population is estimated to rise by 2 billion in the next three decades to
Trxade (MEDS) aims to take on pharmacy chains with an alternate online network
Online pharmaceutical purchases have seen a steady increase in the US over the past decade and the pandemic is now expected to
Pandemic will drive rapid adoption of new network architectures: Fastly CFO Adriel Lares
Companies are increasingly recognizing the importance of digital transformation not only to survive during these uncertain times but also for long-term success,
360 Finance will boost loan origination volume in Platform Services unit: CFO Jiang Wu
At a time when the business world is facing unprecedented uncertainty, 360 Finance, Inc. (NASDAQ: QFIN) is counting on its risk strategy
Niu Technologies (NIU) sees favorable urban mobility trends as markets evolve
China is one of the fastest-growing electric vehicle markets, thanks to the aggressive green energy campaign and subsidies offered by the government
Data analytics has never been more critical: Alteryx CFO Kevin Rubin
COVID-19 presented a kind of global disruption that was least expected by businesses and world leaders. And the pandemic was worst hit
Pandemic has contracted Fiverr’s profitability timeline by a year
It might be incorrect to say that the global pandemic is bringing about a lifestyle change. It is only accelerating the change
ImmunoGen CEO Mark Enyedy speaks on product strategy, pipeline and more
COVID-19 has been pretty disruptive on clinical-level biotech and pharmaceutical companies worldwide, especially those running on tight budgets. Clinical trials have been
Why investors need to take note as Veru Inc transforms into a prostate cancer firm
According to the American Cancer Society, prostate cancer is the second most common form of cancer among men in the US, affecting almost